Editor's Note Video laryngoscopy was found to lead to higher intubation success rates over direct laryngoscopy in critically ill adult patients, an August 2023 randomized controlled trial published by the The New England Journal of Medicine shows. The findings were consistent whether they were intubated in an emergency room or…

Read More

Editor's Note In this investigative study done by the Boston Medical Center (BMC), patients were shown more likely to agree to participate in clinical studies when approached by research staff of the same race or ethnicity as them. The findings were published in JAMA Ophthalmology on October 19.  The study…

Read More

Editor's Note A new study in the Annals of Thoracic Surgery finds that long-term survival rates are extremely promising for patients who receive low-risk isolated surgical aortic valve replacement (SAVR). The study, titled "Survival Following Surgical Aortic Valve Replacement in Low-Risk Patients: A Contemporary Trial Benchmark," was published on October…

Read More

Editor's Note A 5-day limit on opioid pain medication prescriptions in Michigan did not negatively impact patient-reported pain levels or satisfaction, JAMA Network October 13 reports. The study, titled "Changes in surgical opioid prescribing and patient-reported outcomes after implementation of an insurer opioid prescribing limit," was published by JAMA Health…

Read More

Editor's Note A new nasal vaccine in development by Griffith University’s Institute for Glycomics in Australia could provide long-term protection against the deadly bacteria Streptococcus A (Strep A), Griffith University's Griffith News October 5 reports. Strep A causes 700 million human infections each year, and there are more than 500,000…

Read More

Editor's Note In a first of its kind surgical procedure, doctors have installed artificial intelligence (AI) implants in the brain of a 46-year-old man who was paralyzed from a fall on the ice, CNN September 27 reports. The AI implant formed a "digital bridge"–an idea pioneered by the French neuroscientist…

Read More

Editor's Note Eisai, the Japanese drug maker, said on Tuesday September 27, that its experimental drug for Alzheimer’s disease helped slow cognitive decline to those experiencing early stages of the illness. In the phase 3 clinical trials, the drug, called lecanemab, slowed cognitive decline by 27% after 18 months, the…

Read More

Editor's Note In this clinical trial, scientists at University College London and the University of Sheffield found that robot-assisted surgery to remove and rebuild bladder cancer allowed patients to “recover much faster and spend considerably (20%) less time” in the hospital, SciTechDaily June 13 reports. Other findings included 52% less…

Read More

Editor's Note Cardiologists at the University of Washington School of Medicine (UW Medicine) in Seattle, Washington, are participating in a national clinical trial to test a device designed to control bleeding if a vessel near the heart is inadvertently perforated during a catheter-based procedure, Healthcare Purchasing News May 26 reported.…

Read More